Present & Future of Pharmacological Interventions in Pediatric Obesity: Who, When & Which?
Track
:
CLINICAL
Program Code:
S41-2
Date:
Sunday, June 5, 2011
Time:
4:15 PM to 4:45 PM
EST
Location:
205ABC
SPEAKER
:
Jean-Pierre Chanoine, MD,PHDe, British Columbia Children's Hosp Disclosure: Nothing to Disclose
Jean-Pierre Chanoine, MD, PhDe Dr. Chanoine is a Pediatrician who graduated from the Free University of Brussels, Belgium in 1982. He joined the University of British Columbia in 1998 as Clinical Professor and Head of the Endocrinology and Diabetes Unit at British Columbia’s Children’s Hospital. Dr Chanoine is Director of the subspecialty research component attached to the center for Healthy Weights Program, Shapedown BC, a clinical program addressing the needs of overweight children at British Columbia Children’s Hospital. He is also director of the Pediatric component of the Canadian Obesity Network. His previous experience includes a fellowship at the University of Massachusetts Medical Center in Worcester, USA; Pediatric Endocrinologist at Hôpital des Enfants Reine Fabiola in Brussels; and Medical Director for Novo Nordisk Belgium. He is presently President of the Canadian Pediatric Endocrine Group. Dr Chanoine’s research is focusing on the role of hormonal and nutritional factors in the development of childhood overweight. The main line of research includes laboratory-based projects aimed at understanding the physiological role of ghrelin, an orexigenic peptide, during the fetal and early postnatal period and clinical projects looking at the role of appetite-regulating hormones in the development and treatment of childhood and adolescent overweight. Dr Chanoine is also principal investigator of “Healthy Buddies”, a peer-led curriculum aiming at preventing the development of overweight in elementary school children.